This inventor holds 1 USPTO granted patent. Top assignee: Ripple Therapeutics Corporation. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations by Elizabeth Poloz in Pharmaceutical Development
Introduction
Elizabeth Poloz is an accomplished inventor based in Kitchener, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel drug formulations. Her work focuses on enhancing the efficacy and delivery of medications, which is crucial for improving patient outcomes.
Latest Patents
Elizabeth Poloz holds a patent for "Crystalline forms of dexamethasone dimers and uses thereof." This patent features polymorphs of a prodrug dimer of dexamethasone linked at the 21-C and 21'-C carbons via a carbonate-triethylene glycol-carbonate linker. The disclosure includes pharmaceutical compositions and articles comprising these polymorphs, as well as their use in treating various diseases or conditions through the extended or controlled release of dexamethasone.
Career Highlights
Elizabeth is currently associated with Ripple Therapeutics Corporation, where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to advancing drug delivery systems and improving therapeutic efficacy.
Collaborations
Elizabeth collaborates with notable colleagues, including Ian Charles Parrag and Matthew Alexander John Statham. These partnerships enhance her research and development efforts, contributing to the advancement of pharmaceutical technologies.
Conclusion
Elizabeth Poloz is a pioneering inventor whose work in pharmaceutical innovations is making a significant impact in the field. Her contributions, particularly in the development of dexamethasone dimers, showcase her dedication to improving healthcare solutions.